Shows
LARVOL Onco Data PodcastLARVOL Onco Data Podcast with Dr. Mark Gramling and Bruno Larvol | Post ASTRO | E.33In this episode of the LARVOL Onco Data Podcast, Bruno Larvol and Dr. Mark Gramling dive into key findings from ASTRO 2024. They explore some of the top insights presented at the conference, analyzing their impact and the reaction across social media and within the oncology community. Listeners will also learn how LARVOL CLIN offers insights through data analytics and social media response tracking for conferences like ASTRO. If you're involved in oncology research or pharma, this episode is packed with ways to make the most of conference data and highlights how you can explore these tools for your next...
2024-11-0413 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Monika Lamba Saini | E.34Dr. MONIKA LAMBA SAINI joins Dr. Mark Gramling for a broader discussion beyond the usual trial-focused topics in this episode. This time, they explore the world of pathology and the latest technological advancements.Key points include:• The clinical applications of technology in pathology, where Dr. Monika shares insights from her experience in both molecular and digital pathology.• How AI is playing a role in diagnostic applications and how pathologists work and improve patient outcomes.Dr. Monika Lamba Saini, MBBS, MD, Ph.D., is the ‘Global Translational Pathology leader’ at ADC Therapeutics, where she is r...
2024-11-0419 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast: Post-World Lung Analysis with Christian Hayden from Opus Strategy | E.29Join us for an episode of the LARVOL Onco Data Podcast where Mark Gramling, VP of Oncology at LARVOL, hosts Christian Hayden from Opus Strategy for a Post-World Lung Cancer Conference (WCLC) analysis. Mark and Christian dive into key discussions surrounding emerging oncology targets and reflect on the recent Tropion trial’s ups and downs. They provide valuable insights into the latest data, exploring the landscape of new targets and therapies in different markets and geographies. 💡 Key Topics Discussed: • Reflections on the Tropion trial and its implications in oncology • Analyzing new targets and their impact across various geographies Don’t miss this...
2024-10-0714 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Kevin Punie | E.30🎙️ LARVOL Onco Data Podcast with Dr. Kevin Punie In this episode of the LARVOL Onco Data Podcast, Dr. Kevin Punie joins host Dr. Mark Gramling to discuss the latest insights from ESMO, focusing on key abstracts and social media reactions from the oncology community. Together, they explore critical updates in oncology, including a deep dive into triple-negative breast cancer and how new data is shaping clinical practices. Tune in for an engaging conversation that highlights the role of social media in driving oncology discourse and the future of cancer treatment. For more conference insights and data, visit clint.larvol.com a...
2024-10-0718 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Opus Strategy | E.31Post-ESMO - European Society for Medical Oncology Insights with Christian Hayden from Opus Strategy, LLC and Mark Gramling In this episode of the LARVOL Onco Data Podcast, Mark Gramling teams up with Christian Hayden from Opus Strategy to deliver rapid-fire insights following the ESMO conference. They dive into the outcomes of the Tevosa trial, discussing how, despite some disappointing results, the trial addressed critical research questions that will guide future oncological treatments. Christian and Mark also explore the role of clinical research in shaping oncology care and how findings like these influence oncologists’ decisions worldwide. The conversation balances analysis wi...
2024-10-0715 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Dr. Amol Akhade & Dr. Guru Sonpavde | Post-ESMO | E.32In this engaging episode of the LARVOL Onco Data Podcast, Guru Sonpavde, MD, and Dr. Amol Akhade delve into key takeaways from the latest oncology discussions at ESMO24. The conversation highlights the expanding treatment options for physicians. Our VP of Oncology, Dr. Mark Gramling, emphasized the importance of focusing on the optimal sequencing of treatments like Ambassador, Niagara, EV-302, and Litespark. While more study is needed to determine the best approach, having these additional options is a win for patient care. Dr. Guru shares his thoughts on these important trials and how they have shaped recent discussions in GU...
2024-10-0729 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO | Bruno Larvol | Mark Gramling | E.18LARVOL ONCO DATA Podcast: Post-ASCO Insights with Mark Gramling and Bruno Larvol Join hosts Mark Gramling and Bruno Larvol for an episode of the LARVOL Onco Data Podcast as we go through the latest insights and discoveries from the recent ASCO conference. 🔍 Exploring ASCO Highlights: Highlighting key takeaways from ASCO as we analyze the most significant advancements, trials, and presentations in oncology. 💡 Analysis: Gain insights as we discuss the latest research findings. 📊 Data-driven Discussions: Join us for a data-driven discussion for navigating the landscape of oncology research and development. Don’t miss the latest post-ASCO insights. Tune in to the LARVOL...
2024-10-0717 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO | Dr. Kai-Keen Shiu | E.20LARVOL Onco Data Podcast: ASCO Insights with Dr. Kai-Keen Shiu and Mark Gramling Join us for an episode of the LARVOL Onco Data Podcast, where host Mark Gramling and guest Dr. Kai-Keen Shiu delve into the insights from the American Society of Clinical Oncology (ASCO). This episode will focus on the impact and applications of the LARVOL CLIN Platform in interpreting and utilizing ASCO data. 🔍 ASCO Insights: Uncover key takeaways from the recent ASCO meeting, as Dr. Shiu and Mark Gramling discuss the research and emerging trends in oncology. 💡 LARVOL CLIN Platform: Explore how LARVOL CLIN enhances understanding and applic...
2024-10-0716 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Dr. Arturo LoAlza-Bonilla | E.21LARVOL ONCO DATA Podcast: Insights with Bruno Larvol and Arturo LoAIza-Bonilla MD Join Bruno Larvol for an episode of the LARVOL ONCO DATA Podcast featuring Dr. Arturo LoAlza-Bonilla, Co-Founder of Massive Bio and Medical Director of Oncology Research at Capital Health. 🔍 Dr. LoAlza-Bonilla shares his expertise on the latest oncology research and treatment advancements. 💡 Innovative Approaches: Explore the methodologies used in oncology today, including the impact of AI and data-driven analytics on patient care and research. 🌐 Collaborative Efforts: Learn about the importance of collaboration in oncology, as Dr. LoAlza-Bonilla highlights how multidisciplinary efforts are driving progress in cancer care. Don’t mis...
2024-10-0718 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Guru Sonpavde, MD | E.22Join hosts Mark Gramling and special guest Dr. Guru Sonpavde, MD, for an insightful episode of the LARVOL ONCO DATA Podcast, focusing on the latest advancements and research in bladder cancer. 🔍 Bladder Cancer Insights: Dr. Sonpavde, a leading expert in oncology, shares his knowledge on the current trends and future directions in bladder cancer research and treatment. 💡 LARVOL CLIN in Action: Discover how the LARVOL CLIN platform is being leveraged to provide real-time analytics and insights into bladder cancer, enhancing the understanding and management of this complex disease. 🌐 Innovative Approaches: Explore cutting-edge technologies and methodologies being applied in bladder cancer re...
2024-10-0717 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Deep Dive into EHA with Christian Hayden | E.23Deep Dive: Post-EHA 2024 Analysis | Join us for a special podcast featuring LARVOL's Mark Gramling in conversation with Christian Hayden, Director at Opus Strategy, LLC, as they take a deep dive into the recent European Hematology Association (EHA) conference. 🔍 EHA Insights: Gain insights into the key takeaways and groundbreaking research presented at EHA. Christian Hayden and Mark Gramling will explore the most significant advancements and their potential impact on hematology. 💡 Analysis: Christian Hayden brings his strategic expertise to the discussion, providing analysis and perspectives on the trends and developments in hematology research. 🌐 Implications for Practice: Discover how the findings from EHA can b...
2024-10-0716 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Darko Medin | E.24Join us for another of the LARVOL ONCO DATA Podcast, where host Mark Gramling is joined by guest Darko Medin, an expert in AI and machine learning applications in oncology. AI in Oncology: Darko Medin shares his insights on how these advanced technologies are revolutionizing oncology data analysis. Innovative Applications: Learn about the latest innovations in AI and how they are being utilized to improve accuracy, planning, and patient outcomes in oncology. Real-World Implications: Gain valuable perspectives on the real-world implications of integrating AI in oncology. Tune in to the LARVOL ONCO DATA Podcast.
2024-10-0717 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Opus Strategy | Laura Farmer | Shabaz Khan | E.25LARVOL ONCO DATA Podcast: Collaborative Innovations in Oncology with Opus Strategy, LLC Join us for an episode of the LARVOL ONCO DATA Podcast, hosted by Mark Gramling, featuring Laura Farmer, President of Opus Strategy, and Shabaz Khan, Consultant at Opus Strategy. LARVOL and Opus share a close partnership, often working together to advance oncology research. In this episode, we explore projects that are transforming oncology: 🔍 Collaborative Innovation: LARVOL & Opus Strategy Discover how the partnership between LARVOL and Opus Strategy drives innovation in oncology. Learn about joint projects and shared expertise that enhance data-driven decision-making in cancer research. 💡 Spotlight on Data I...
2024-10-0715 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Mark Gramling and Shaheer Shaikh | E.26LARVOL ONCO DATA Podcast: Exploring LARVOL Clin with Mark Gramling Join us as Shaheer Shaikh hosts Mark Gramling in a discussion on the latest developments with LARVOL Clin. In this episode, Mark introduces LARVOL Clin, shares exciting upcoming coverage, and highlights the newest updates that are enhancing the platform’s impact on oncology research and clinical decision-making. 🔍 Key Discussion Points: An overview of LARVOL Clin and its role in advancing oncology research. Upcoming coverage and events to keep an eye on for the latest in oncology insights. New updates and features that are making LARVOL Clin even more valuable for u...
2024-10-0716 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Mark Gramling | E.27LARVOL ONCO DATA Podcast: AI and Outcomes Predictions with Mark Gramling In this solo episode, Mark Gramling dives into the role of AI in predicting outcomes within oncology. Mark discusses how AI technologies are being leveraged to forecast clinical outcomes and improve patient care. Additionally, he highlights upcoming events where these advancements will be showcased. 🔍 What to Expect: • Insights into the latest AI advancements and their practical applications in clinical practice • An overview of upcoming events where these AI-driven innovations will be featured Join us to explore what to look forward to in the upcoming events.
2024-10-0715 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast with Dr. Wafik S. El-Deiry and Dr. Mark Gramling | E.28Join Dr. Wafik S. El-Deiry, and Dr. Mark Gramling as they discuss the potential of immune response in future cancer treatments and the challenge of managing rapidly evolving oncology data. They explore how clinicians navigate new genetic insights and the continuous progress in cancer research. 🔍 Highlights: • Future potential of immune-based cancer cures • Navigating the ever-growing landscape of oncology data Listen in for insights on the evolving challenges and opportunities in oncology. #Oncology #CancerResearch #LARVOL
2024-10-0717 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO / EHA | E.19LARVOL ONCO DATA Podcast with Mark Gramling Join Mark Gramling, VP of Oncology at LARVOL, for a solo exploration into the latest developments and insights from the world of oncology data. 🔍 Exploring LARVOL CLIN’s Impact: Dive into how LARVOL CLIN leverages social media reactions and data analytics to provide real-time insights post-ASCO and a preview of upcoming data from EHA. 💡 Social Media Insights: Discover the buzz and reactions surrounding key oncology trials and research. 📊 Preview of ASCO Extracted Data: Get a sneak peek into the data extracted from ASCO and its implications for future oncology research and clinical practice. S...
2024-10-0713 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO | E.17🎙️ LARVOL ONCO DATA Podcast: ASCO 2024 Insights Join hosts Mark Gramling and Bruno Larvol for another episode of the LARVOL ONCO DATA Podcast, where we follow the latest trends and insights shaping the oncology landscape. Exploring Social Media Reactions: Get access to the latest social media reactions from top oncologists on LARVOL CLIN. Discover the buzz surrounding groundbreaking trials, including HARMONi, LAURA, and ADRIATIC, as we analyze the implications and reactions from the oncology community. Engage with Industry Leaders: Connect with us live at ASCO and learn more about LARVOL CLIN. Engage with industry leaders, explore new opportunities, and gain valua...
2024-06-0714 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Pre-ASCO Prep | E.16🎙️ LARVOL ONCO DATA Podcast: Preparing for ASCO with Data Analytics, Social Media Reactions, & Conference Planning Join Mark Gramling and Bruno Larvol for another episode of LARVOL ONCO DATA Podcast as they gear up for the upcoming ASCO conference. This pre-ASCO episode will focus on the essential aspects of data analytics, social media reactions, and conference planning. 🌐 Exploring ASCO Preparations: Gain insights into the latest preparations and expectations for the upcoming ASCO conference, including strategies for effective data analytics, monitoring social media reactions, and comprehensive conference planning. 💡 Data Analytics Insights: Discover how data analytics are shaping the landscape of oncology research an...
2024-06-0718 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | AACR | Bluestarbio | E.11🎙️ LARVOL ONCO DATA Podcast: AACR Insights with Mark Gramling, Judith Perez, and Erin Olsen from Bluestarbio Advisors Join us for an episode of LARVOL ONCO DATA Podcast as we unpack the latest developments from the American Association for Cancer Research (AACR) conference. Our hosts, Mark Gramling and Judith Perez from LARVOL, along with Erin from Bluestarbio Advisors, share their perspectives and insights. 🌐 Reflecting on AACR: Dive into the highlights and key takeaways from AACR, one of the most significant events in the field of cancer research. 💡 Expert Analysis: Gain valuable insights from our panelists as they analyze the latest research fi...
2024-06-0515 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | PRE-ASCO | Dr. Amol Akhade | E.15🎙️ LARVOL ONCO DATA Podcast: Preparing for ASCO with Dr. Amol Akhade Join hosts Mark Gramling and Judith Pérez Granado for an episode of LARVOL ONCO DATA Podcast as they prepare for the upcoming ASCO conference. This episode features a discussion with guest Dr. Amol Akhade, where they delve into the intersection of LARVOL CLIN and ASCO. 🌐 Exploring ASCO Preparations: Gain insights into the latest preparations and expectations for the upcoming ASCO conference, one of the largest gatherings in oncology. 💡 LARVOL CLIN Insights: Discover how LARVOL CLIN is shaping the landscape of oncology research and how it can enhance your experie...
2024-06-0516 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Pre-ASCO | Mark Gramling & Judith Perez | E.14🎙️ LARVOL ONCO DATA Podcast: Pre-ASCO Insights with Mark Gramling and Judith Pérez Join us for an episode of LARVOL ONCO DATA Podcast as we delve into pre-American Society of Clinical Oncology (ASCO) insights. Our hosts, Mark Gramling and Judith Perez, share their perspectives on the upcoming ASCO conference. 🌐 Previewing ASCO: Get a sneak peek into the advancements, trends, and hot topics in oncology as we prepare for the upcoming ASCO conference, one of the largest gatherings of oncology professionals worldwide. 🔍 Preparation Strategies: Discover how LARVOL is gearing up for ASCO, and learn about strategies and tools to maximize the conferen...
2024-06-0517 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Cadence Communications & Research | Pre-ASCO | E.13🎙️ LARVOL ONCO DATA Podcast: Pre-ASCO Insights with Mark Gramling, Linh Nguyen, Sugata Biswas, and Zachary Moore Get ready for another episode of LARVOL ONCO DATA Podcast as we dive into pre-American Society of Clinical Oncology (ASCO) insights. Join our hosts, Mark Gramling and Linh Nguyen, along with guests Sugata Biswas, Founder at Cadence Communications & Research, and Zachary Moore, for a dynamic discussion. 🌐 Previewing ASCO: Explore the advancements, trends, and topics in oncology as we preview the upcoming ASCO conference, one of the largest gatherings of oncology professionals worldwide. 💡 Expert Perspectives: Gain insights from our panelists as they share their expertise...
2024-06-0517 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Introduction to Network Meta-Analysis | Darko Medin | E.12LARVOL Onco Data Podcast! In this episode, we are thrilled to have Darko Medin, an expert in biostatistics and data analysis, join us for an insightful discussion on Network Meta-Analysis (NMA).Network Meta-Analysis is a powerful tool that combines data from multiple studies to compare different treatments for the same condition. Darko Medin will break down the fundamentals of NMA, explain its significance in oncology research, and discuss how it helps in making informed clinical decisions.Whether you're a healthcare professional, researcher, or just interested in the latest in oncology data analysis, this episode provides valuable...
2024-06-0515 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Exploring AI Voices with Top AI Voice Expert | Matt Lewis | E.9In this episode of Larvol Onca Data Podcast, we sit down with Matt Lewis, a leading expert in AI voice technology, to explore the fascinating world of artificial intelligence voices. Matt shares his insights on the latest advancements, the impact of AI voices on various industries, and what the future holds for this rapidly evolving technology. Tune in to hear about the challenges and opportunities in developing realistic and expressive AI voices, and how they are transforming communication, entertainment, and beyond.#Podcast #AIVoice #Technology #MattLewis #ArtificialIntelligence #Innovation #FutureTech #Larvol #Oncology
2024-06-0516 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | AACR | E.10🎙️ LARVOL ONCO DATA Podcast: Insights from AACR Tune in to the latest episode of LARVOL ONCO DATA Podcast, where hosts Mark Gramling and Bruno Larvol bring you discussions centered around the American Association for Cancer Research (AACR) conference. 🌐 Exploring AACR: Delve into the highlights and key findings from the AACR conference, a pivotal event in the field of cancer research. 💡 Expert Analysis: Gain valuable insights from Mark and Bruno as they analyze the latest advancements and breakthroughs presented at AACR. 🔍 Practical Applications: Discover how these insights from AACR are shaping the future of cancer research and treatment, with a focus on real...
2024-06-0513 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Real World Evidence in Oncology & Patient-Reported Outcomes | Renee Pierson | E.8Join us for an in-depth exploration of how real-world evidence (RWE) is transforming oncology research and regulatory decision-making. This video delves into the importance of patient-reported outcomes (PROs) in understanding the true impact of cancer treatments on patients' lives. Learn from leading experts about the current regulatory landscape, key challenges, and future directions for integrating RWE and PROs in oncology. Don't miss this essential discussion for healthcare professionals, researchers, and policymakers!#Oncology #RealWorldEvidence #PatientReportedOutcomes #Healthcare #RegulatoryScience #CancerResearch
2024-06-0416 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Mark G | E.7Join hosts Mark Gramling and Bruno Larvol as they navigate through the complexities of hazard ratio, a cornerstone statistic in oncology studies. Hazard ratio serves as a powerful tool for assessing the relative risk of an event occurring between two groups, such as patients receiving different treatments or exposed to varying risk factors.In this enlightening discussion, we explore how hazard ratio influences decision-making in cancer research and treatment. From its interpretation in survival analysis to its implications for treatment efficacy and patient outcomes, we'll uncover the profound impact of hazard ratio on shaping the landscape of...
2024-06-0414 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Pre-ASH | E.1🎙️ LARVOL ONCO DATA Podcast: Episode 1 - with Bruno Larvol and Mark Gramling Embark on a journey with the debut episode of LARVOL ONCO DATA Podcast! Join Mark Gramling, VP of Oncology at LARVOL, in a conversation with Bruno Larvol as they unveil Episode 1, a special PRE-ASH Conference edition. 🌐 Navigating the ASH Landscape: Dive into the heart of hematology's most anticipated event, the American Society of Hematology (ASH) Conference. Discover how LARVOL CLIN, with its innovative use of Natural Language Processing (NLP), Artificial Intelligence (AI), and Expert Analyst Curation, adds unparalleled value to your ASH conference preparation. 📊 Real-Time Insights for ASH: Experi...
2024-05-3130 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | Post-ASH | Judith Pérez Granado | E.2🎙️ LARVOL ONCO DATA Podcast: Post-ASH Insights with Judith Pérez and Bruno Larvol. Embark on a journey into the post-ASH landscape with a dynamic episode of LARVOL ONCO DATA Podcast! Bruno Larvol and Judith Perez, offering dual perspective on the latest advancements. 🌐 Navigating Post-ASH: Explore the aftermath of the American Society of Hematology (ASH) Conference. Gain invaluable insights into emerging trends, key takeaways, and the transformative impact on the future of hematology. 🔍 Expert Analysis: Expert analysis on the wealth of data and discussions that unfolded at ASH. Learn how LARVOL CLIN continues to revolutionize the interpretation of complex hematology information...
2024-05-3129 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | PRE-JPM | Mark G | E.3Join us for another episode of LARVOL ONCO DATA Podcast with your hosts Mark Gramling and Bruno Larvol. In this session, we are discussing the intricacies of leveraging Generative AI and Large Language Models (LLM) within the realm of our extensive cancer dataset. 🌐 Unlocking Insights: Learn more about LARVOL CLIN as Mark Gramling and Bruno Larvol share their experiences in utilizing Generative AI and LLM. Explore the techniques applied to unlock insights from our vast oncology dataset. Our goal today is transparency. We'll discuss our successes and failures in applying LLM to oncology data, providing a glimpse into the lan...
2024-05-3119 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO GI Prep | Judith Perez & Mark G | E.4🎙️ LARVOL ONCO DATA Podcast: ASCO GI Prep with LARVOL CLIN Join us for an episode of LARVOL ONCO DATA Podcast as we gear up for the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI). Our hosts, Mark Gramling and Bruno Larvol, along with Judith Pérez, Director of Data Science, share insights on how LARVOL CLIN is making a difference. 🌐 Getting Ready for ASCO GI: Explore the world of oncology as we get ready for the ASCO GI Symposium. Discover the latest trends and insights that will be important at this event. 📊 Data Science in Action: Judith Pérez, a dat...
2024-05-3115 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO GI | Judith P & Mark G | E.5Join us for another episode of LARVOL ONCO DATA Podcast as we reflect on the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) with a focus on LARVOL CLIN. Our hosts, Mark Gramling and Bruno Larvol, along with Judith Pérez, Associate Director of Data Science, share insights. 🌐 Recapping ASCO GI: Dive into the highlights and explore key takeaways. 💡 LARVOL CLIN Impact: Actionable insights for the oncology community. 🔍 Gain insights into how LARVOL is applying the lessons learned from ASCO GI & bringing real-world value to oncology professionals. Join us for an episode that showcases the practical implications of LARVOL...
2024-05-3115 minLARVOL Onco Data PodcastLARVOL Onco Data Podcast | ASCO GU | Judith P & Mark G | E.6🎙️ LARVOL ONCO DATA Podcast: Insights from ASCO GU with LARVOL CLIN Join us for an episode of LARVOL ONCO DATA Podcast as we delve into insights from the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), with a spotlight on LARVOL CLIN. Our hosts, Mark Gramling and Bruno Larvol, along with guest Judith Pérez, Director of Data Science, share valuable takeaways. Recapping ASCO GU: Explore the highlights and key learnings from ASCO GU, a significant event in the field of genitourinary oncology. LARVOL CLIN's Role: Learn about the impact of LARVOL CLIN at ASCO GU and its ro...
2024-05-3113 min
Laboratory Considerations for Clinical TrialsAI in Pathology: Advancements, Challenges, and the Road AheadIn this episode Dr. Monika Lamba Saini and Bruno Larvol of “LARVOL & Friends” discuss the role of artificial intelligence (AI) in pathology and its potential impact on healthcare.
They delve into the slower adoption of AI in pathology compared to other medical specialties and examine the challenges that lie ahead. The conversation explores the need for regulatory approval, integration with hospital systems, and standardization of AI solutions in pathology. Dr. Saini shares insights on image recognition, the digitization of healthcare, and the transformative potential of AI in diagnostic algorithms.
Listen to gain a deeper understanding of t...
2023-06-3028 min
LARVOL & FriendsAI in Pathology: Advancements, Challenges, and the Road Ahead with Dr. Monika Lamba Saini (E.15)In this episode of "LARVOL & Friends" Bruno Larvol and Dr. Monika Lamba Saini discuss the role of artificial intelligence (AI) in pathology and its potential impact on healthcare. They delve into the slower adoption of AI in pathology compared to other medical specialties and examine the challenges that lie ahead. The conversation explores the need for regulatory approval, integration with hospital systems, and standardization of AI solutions in pathology. Dr. Saini shares insights on image recognition, the digitization of healthcare, and the transformative potential of AI in diagnostic algorithms. Join the discussion to gain a de...
2023-06-1427 min
LARVOL & FriendsGenerative AI & Healthcare with Darko Medin (E.14)Dive into the fascinating world of AI in healthcare with host Bruno Larvol in this riveting episode of "Larvol & Friends". Darko Medin, acclaimed Biostatistician and Data Science Guru, joins the discussion to illuminate the transformative power of "Generative AI & Healthcare". From revolutionizing drug discovery to customizing patient care, the insights offered are mind-blowing. Tackling complex topics like ethical quandaries and data privacy, this episode is a thrilling rollercoaster ride at the intersection of technology and medicine that you don't want to miss!
2023-06-0830 min
LARVOL & FriendsGenerative & Conversational AI with Shyamala Prayaga (E.12)In this episode of "LARVOL & Friends", join Bruno Larvol and Shyamala Prayaga, an expert in generative and conversational AI, as they dive into the fascinating world of AI technology. The conversation revolves around the capabilities and applications of generative and conversational AI in various fields. Prayaga sheds light on how these advanced AI techniques can create realistic and human-like text, enabling tasks like generating creative content, virtual assistants, and chatbots. Gain an insight into the evolving landscape of AI and its impact on industries ranging from customer service to content creation, as this episode offers a captivating g...
2023-05-3127 min
LARVOL & FriendsTrends in Medical Affairs with Sherry Crowe (E.11)In this episode of LARVOL & Friends, Bruno sits down with Sherry Crowe, executive vice-president of PrecisCa, to explore the fascinating world of Oncology Medical Affairs. They discuss the current trends shaping the field and share insightful predictions for the future of medical affairs engagement.🔥 Sherry's advice for those feeling stuck or burned out is pure gold: follow your passion, pivot when needed, and prioritize self-care. Embrace new challenges, build connections, and create your own value for career success. 🚀
2023-05-2429 min
LARVOL & FriendsAI & Healthcare with Matt Lewis (E.10)As the healthcare industry continues to face complex challenges, artificial intelligence offers a potential solution. In this episode, Matt Lewis, Co-Founder of Inizio Medical Analytics and Innovation, joins the show to discuss the intersection of AI and healthcare. Together with host Bruno Larvol, the two explore the fundamentals of AI and how it is already impacting healthcare. From deep learning and cognitive computing to predictive modeling and decision support systems, we explore the latest insights into this exciting and rapidly evolving field.
2023-05-0931 min
LARVOL & FriendsHealth & Innovation with Gil Bashe (E.4)In this episode of "LARVOL & Friends", host Bruno Larvol chats with health innovation and patient care expert Gil Bashe about the future of medicine and the role of AI innovation in driving change. From AI-powered diagnostics to personalized medicine, the two explore the latest trends and breakthroughs in healthcare innovation. With insights from his years of experience working with healthcare companies and advocacy groups, Bashe offers a visionary outlook on the future of healthcare and highlights the challenges we face to improve our daily well-being with the use of virtual reality. Whether you're a healthcare professional or simply interested...
2023-05-0427 min
LARVOL & FriendsDOLs in 2023 with Sarah Snyder (E.6)In this episode, join our host & CEO Bruno Larvol and Sarah Snyder, a pharmacist and renowed Medical Affairs recruiter, to discuss the role of Digital Opinion Leaders (DOLs) in 2023. The conversation delves into the evolving landscape of influencer marketing and the impact of DOLs in shaping public opinion and driving consumer behavior. Snyder provides valuable insights into the strategies and best practices for effectively partnering with DOLs to amplify brand messaging and engage target audiences. This episode sheds light on the importance of transparency, authenticity, and ethical considerations when leveraging DOLs as influential voices in the digital realm. Give...
2023-05-0429 min
LARVOL & FriendsDigital Innovation & Health Tech with Ana Maria Palusci (E.9)In this thought-provoking episode, join Bruno and Ana Maria Palusci, Vice President of Business Development at Bill Gosling Outsourcing, as she shares her insights on the intersection of technology and healthcare. The conversation explores the rapidly evolving landscape of digital innovation in the healthcare industry. Palusci discusses the transformative potential of health tech solutions and she highlights the opportunities and challenges that come with integrating technology into healthcare delivery. This episode provides a fascinating exploration of how digital innovation is reshaping the healthcare landscape and improving patient care. Give it a listen to gain valuable insights into t...
2023-05-0427 min
It's about the triple aim!A Conversation with Bruno Larvol Founder & CEO LARVOLOn today's episode of Health UnaBASHEd, our guest is Bruno Larvol (FOAM) Founder & CEO at LARVOL, a VR-first, remote-always organization providing SaaS solutions to 15 Fortune 500 healthcare and pharmaceutical companies.
Since 2004, LARVOL has accelerated decision-making via real-time, customized intelligence and software solutions with data-driven analytics to the most prominent pharmaceutical, biotech, and healthcare companies in the world.
Bruno is a uniquely insightful executive and entrepreneur walking the talk of iterative, distributed team based learning and both advocate and innovator for real world applications in the metaverse.
Follow Bruno's work at LARVOL on twitter via @Larvol and @RXXO, respectively and on the web...
2023-02-1629 min
MSL TalkHow MSLs can WIN with Social Media in Medical AffairsIn this episode, Tom Caravela is joined by Bruno Larvol to explore the intersection of medical science liaisons (MSLs) and social media. They discuss the importance of social media engagement, addressing compliance concerns, and the value of social media listening for MSLs. The conversation includes strategies for leveraging social media insights, building a professional brand, and distinguishing between key opinion leaders and digital opinion leaders. Bruno and Tom also delve into social media's impact on recruitment, career development, and time allocation, while promoting progressive engagement policies. The episode concludes with insights on the future of podcasting and the metaverse.
...
2023-01-0336 minMSL TalkVirtual Reality and Medical Affairs in the MetaverseIn this episode, Bruno Larvol joins the discussion to explore the metaverse and its potential impact on medical affairs. The conversation delves into the significance and future applications of the metaverse for Medical Science Liaisons (MSLs) and medical affairs departments, highlighting both opportunities and challenges of its integration. The episode examines the growing interest of the pharmaceutical and biotech industries in the metaverse, including its social implications. Concepts such as Ready Player 1, digital museums, and NFTs are discussed to illustrate the metaverse's potential. Bruno Larvol concludes with insights on the evolving landscape, followed by closing remarks and sponsor acknowledgments.
...
2022-12-0634 min
Pass The MicBruno Larvol, CEO of the MetaverseInterview with CEO, Bruno Larvol - Running a company in the MetaverseBruno Larvol, CEO of LARVOL is running the business from the Metaverse using virtual and augmented reality to explore the next frontier of technology, remote work, and cancer data visualization.There are many conflicting opinions about the Metaverse. It concept has generated a great deal of controversy. Some people believe that the metaverse will revolutionize communication and the exchange of information, while others are concerned that it may provide opportunities for unsavory characters to engage in illicit activities.Listen to our discussion...
2022-08-3118 min
SaugaTalksRunning the Business and Building Trust in Metaverse | SaugaTalks with Bruno Larvol and Yamina HakemSend us a textSaugaTalks with Bruno Larvol, Founder and CEO of LARVOL, a VR-first, remote-always organization of 150+ professionals providing SaaS solutions to 15 Fortune 500 healthcare and pharmaceutical companies, and Yamina Hakem, CEO & Founder at GlobalReach BI, Helping bring the best patient treatments to market through strategic intelligence.TimeCodes:00:00 Company Journey Replacing Physical Proximity with Transparency Creating Trust and Moving to Metaverse 08:33 Most Companies Should Not Be Remote, How Metaverse Tricks Us Back into Physical Proximity15:47 Metaverse Technology Stack Creating Shared Memories and Beautiful Places23:38 The Experience and Effort of Working i...
2022-07-2540 min
Pharmaceutical ExecutiveDigital AwarenessBruno Larvol, CEO and founder of Larvol, discusses how he is invested in the digital world, both personally and professionally, and the impact it can have.
2022-02-0312 min
The "Elevate" by MAPS PodcastSocial Media in Medical Affairs: Beyond Passive ListeningIn this MAPS podcast, we speak with Luca Dezzani, Franchise Head Immuno-Oncology, AstraZeneca and Bruno Larvol, CEO and founder of LARVOL, about the emerging uses of social media in the practice of Medical Affairs including best practices and compliance concerns for Medical Affairs professionals participating in the social media landscape.
2021-03-2421 minThe "Elevate" by MAPS PodcastOpportunity amid volatility, uncertainty, complexity and ambiguity (VUCA) in the changing MSL value propositionEven before the COVID-19 pandemic, the structure and content of interactions between MSLs and KOLs/HCPs was shifting, with MSLs increasingly seen as trusted partners in scientific exchange and KOLs/HCPs increasingly open to technology-based communications. Of course, the pandemic has accelerated this change, shifting the mechanics of communication and collaboration and throwing into focus the definition of “value.” This podcast presents the expertise of leaders from pharmaceutical organizations Pfizer and Nektar, as well as Larvol, focusing on how MSLs bring value to HCPs and KOLs during the time of pandemic.Speakers: · Tim Hylan, VP, Internal...
2020-12-0823 min
PentaLiveLes secrets de l'entreprise 100% virtuellePentaLive par Pentalog
Pouvez-imaginer une entreprise 100% virtuelle ? Pas une entreprise de 3 personnes mais de +100 personnes. Une entreprise où le fondateur n'a rencontré son premier associé qu'au bout de 10 ans. Non ? Bruno Larvol, software entrepreneur franco-américain de la Sillicon Valley, Founder et CEO de Larvol, l'a fait avec succès. Il vient vous raconter comment il a construit, il y a 16 ans, une entreprise 100% virtuelle, profitable, de plusieurs millions de dollars. Tout ça, sans investissement initial extérieur. Les leçons qu'il en a tirées. Les challenges. Les technos. Et pourquoi, cela ne lui vendrait pas à l'idée de f...
2020-05-1335 min
The CEOpeek ShowBuilding Remote Global Teams - Bruno Larvol, CEO, Larvol GroupBruno Larvol is the founder of The Larvol Group. Larvol has more than 15 years of successful experience in the pharmaceutical and biotechnology industries. He has worked previously with industry leaders such as The Wilkerson Group / IBM Healthcare Consulting, Lehman Brothers, Sandoz (Novartis), and Abbott. Mr. Larvol founded and served as the Chief Executive Officer of Cognia. He serves on the Biotechnology Advisory Board of the Kellogg Graduate School of Management. He holds an MBA with distinction from the Kellogg School of Management and an MS in biotechnology from Northwestern University.In founding Larvol, Bruno focused on...
2018-04-1607 min